For the Quarter Ending December 2022
North America
Throughout the last quarter of 2022, the North American region, particularly the United States market, showed declining pricing sentiments for Levofloxacin Hemihydrate. At the start of the fourth quarter, prices stayed relatively steady because demand inclined positively compared to the previous month. The different reasons that have affected the market for practically all commodities, including Levofloxacin Hemihydrate, are still closely monitored by market participants as fluctuating prices feared them for their losses. Until November, the prices held on the upper end due to lessening domestic market's overall supplies and healthy demand. With this, the price of Levofloxacin Hemihydrate was significantly demonstrated at USD 67220/MT CFR Los Angeles. After mod q-4 the prices of Levofloxacin Hemihydrate dropped considerably with the closure of the local market on account of New-year breaks.
Asia Pacific
With the end of the Final Quarter of 2022, Levofloxacin Hemihydrate prices in the Asia Pacific area, particularly in China, showed a considerable decline. Until November, China's biggest challenge was handling backed-up logistics on the main trade routes to North America and Europe due to restrictions on the export of all goods, including Levofloxacin Hemihydrate, which also had an impact on the price trends of this drug. In November, in the mid of the fourth quarter, Levofloxacin Hemihydrate prices were set at USD 61770/MT. Following the end of 2022, downstream demand and traders' quotations declined significantly, keeping the prices of Levofloxacin Hemihydrate on the south side.
Europe
During the fourth quarter of 2022, the prices of Levofloxacin Hemihydrate plummeted in the European region. October month witnessed a steadily incremented trajectory as end-user demand from the pharmaceutical sector for Levofloxacin Hemihydrate increased compared to the previous month, i.e., September. Until November, the prices inclined considerably with the settlement of USD 72580/MT CFR Hamburg in Germany and ended in December on the lower side. Furthermore, Levofloxacin Hemihydrate's price trend in November was additionally supported by the ease in supply chain interruption and shipping costs. However, as growing energy prices began to level down at the end of 2022, inflation in Europe declined in December for the second consecutive month, providing somewhat comfort in the prices of Levofloxacin Hemihydrate. On top of that, due to a decline in international orders, notably from exporting nations like China, demand decreased in December, positively supporting the market sentiments.
For the Quarter Ending September 2022
North America
During the third Quarter of 2022, the prices of Levofloxacin Hemihydrate in the North American Region witnessed mixed sentiments. At the onset of the first half of Q3, the prices went down stably with sufficient supplies from the domestic merchants. Further, the prices rose significantly in the mid of q3 owing to increased downstream demand from the end-user sector and enough stocks with the suppliers to meet the overall demand side. Also, affected trading momentum from exporting countries impacted the market sentiments toward Levofloxacin Hemihydrate. Moreover, towards the termination of Q3, the prices showcased a decremented state again with the settlement of USD 63860/MT CFR Los Angeles in the united states.
Asia Pacific
During the third Quarter of 2022, the prices of Levofloxacin Hemihydrate in the APAC region witnessed a fluctuating trend owing to variable downstream demand and the supply side witness. In the first two months of q3, the prices rose significantly, leading to the shortage of stocks with the suppliers, which propelled them to increase their quotations. Additionally, disrupted trading activities leading to delayed shipments and rerouting momentum were another factor that supported the market sentiments of Levofloxacin Hemihydrate in the region. Furthermore, towards the termination of q3, the prices decreased considerably owing to weaker demand and enough supplies with the settlement of USD 56750/MT FOB Shanghai.
Europe
The European region witnessed similar market sentiments in the prices for Levofloxacin Hemihydrate as the APAC region, owing to heightened downstream demand in the market. Also, due to consistent offtakes from the domestic market amid rising input costs, the prices of Levofloxacin Hemihydrate inclined. Across Europe, rising energy costs due to the Russia-Ukraine conflict and the rerouting activities kept the market on the higher side. Furthermore, delayed exports from China due to Covid restrictions on transportation led to low inventories in the regional market till the mid of q3. Towards the termination of q3, the prices for Levofloxacin Hemihydrate went down significantly owing to decremented demand for sufficient supplies with the suppliers. The prices witnessed in September for Levofloxacin Hemihydrate settled at USD 67170/MT CFR Hamburg.
North America
During the second quarter of 2022, the North American region showcased an upsurged pricing sentiment for levofloxacin hemihydrate backed by enhanced downstream demand from end-user enterprises and trading activities in the regional market. Moreover, higher feedstock prices in the market augmented downstream Levofloxacin hemihydrate prices. Rising freight charges and shipment activities also added another value to the prices for Levofloxacin hemihydrate as the commodities are majorly exported from APAC countries. Furthermore, the surging demand caused a shortage of downstream end-products in the market, which caused difficulties for the trader to meet the requirements. Towards the termination of second quarter the prices for Levofloxacin Hemihydrate were settled at USD 62948/MT CFR Los Angeles.
Asia Pacific
APAC region witnessed an upward pricing trajectory for Levofloxacin Hemihydrate during the second quarter of 2022, owing to extended downstream demand and supply disruption in the regional market. Due to unprecedently rising covid cases and trade disruption, levofloxacin hemihydrate prices increased significantly. Additionally, downstream demand caused a shortage of products in the overall domestic and regional market due to delayed shipments. Also, the continual war between Russia-Ukraine led to heightened Feedstock and crude oil prices which augmented the price movement of levofloxacin hemihydrate in the market. Towards the termination of second quarter the prices for Levofloxacin Hemihydrate were settled at USD 56680/MT FOB Shanghai.
Europe
The European region witnessed similar market sentiments in the prices for Levofloxacin Hemihydrate as the North American region, owing to heightened feedstock costs in the market. Also, with respect to feedstock prices in the market, the production activity was heightened, resulting in a higher cost of Levofloxacin hemihydrate. Additionally, surging freight charges due to a shortage of shipments and rerouting activities amid the Russian-Ukraine war caused the prices to spike high of Levofloxacin Hemihydrate. Furthermore, higher downstream demand resulted in a shortage of Stock with the suppliers in the mar, causing difficulty for the manufacturers to meet the rising requirements of customers from the domestic and regional markets. Towards the termination of second quarter the prices for Levofloxacin Hemihydrate were settled at USD 64640/MT CFR Hamburg.
